Data / Drug companies / Avobenzone, octisalate and octocrylene
Avobenzone, octisalate and octocrylene: 4 companies and 19 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Avobenzone, octisalate and octocrylene is listed in the FDA National Drug Code Directory by 4 companies, with 19 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; lotion; spray, and the newest product started marketing on May 27, 2026.
The request: Get every company that lists avobenzone, octisalate and octocrylene in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 4
- Products
- 19
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Topical
- Brand names
- Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Firming AntiWrinkle, Lancome Paris Renergie Lift MultiAction Ultra Lifting Firming Dark Spot Correcting Broad Spectrum SPF 30 Sunscreen, Lancome Paris Renergie HPN 300 Peptide Broad Spectrum SPF 25 Sunscreen, Lancome Paris Visionnaire Broad Spectrum SPF 20 Sunscreen Advanced Multi Correcting All Skin Types, Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Lift and Firming Face and Neck All Skin Types, Lancome Paris Bienfait MultiVital Eye Broad Spectrum SPF 30 Sunscreen, Lancome Paris Bienfait MultiVital Broad Spectrum SPF 30 Sunscreen, Daily Prevention Protect and Refresh Mist SPF 40
- openFDA record search
- api.fda.gov
Companies that list avobenzone, octisalate and octocrylene
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| L'Oreal USA Products Inc | 10 | cream; lotion | Over the counter monograph drugs | June 1, 2023 |
| Sicos Et Cie | 6 | cream | Over the counter monograph drugs | May 27, 2026 |
| L'Oreal USA Products Inc | 2 | cream | Over the counter monograph drugs | May 27, 2026 |
| Allure Labs | 1 | spray | Over the counter monograph drugs | March 21, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 16 | 84.2% |
| Lotion | 2 | 10.5% |
| Spray | 1 | 5.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 19 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.